Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation

J Biol Chem. 2001 Dec 28;276(52):49350-8. doi: 10.1074/jbc.M106289200. Epub 2001 Oct 25.

Abstract

One of the key morphological changes associated with the nerve growth factor (NGF)-induced differentiation of rat adrenal pheochromocytoma (PC-12) cells is the growth of axon-like processes called neurites. A growing body of evidence suggests that this process may be dependent upon plasmin, a serine protease generated from plasminogen (Plg) by either urokinase Plg activator (u-PA) or tissue Plg activator (t-PA). Prior work in our laboratory has identified annexin II (Ann-II) as a co-receptor for Plg and t-PA that promotes and localizes plasmin generation near the cell surface. In the present study, we report a 3-9-fold increase in Ann-II protein and message levels in NGF-treated PC-12 cells. Message stability and nuclear run-on assays suggest that this induction occurs at the level of gene transcription. Neurite outgrowth assays on and within a three-dimensional matrix demonstrate the inhibition of NGF-induced PC-12 cell differentiation by polyclonal and monoclonal antibodies directed against Ann-II as well as by the overexpression of antisense Ann-II mRNA. Neuritogenesis is also impaired by alpha(2)-plasmin inhibitor, antibodies directed against t-PA and u-PA, and epsilon-aminocaproic acid, a lysine analog that inhibits Plg activation and the binding of Plg to Ann-II. Plasmin generation assays reveal a 2-fold increase in plasmin production on NGF-treated PC-12 cells, which can be blocked by a polyclonal antibody directed against the tail region of Ann-II. From these data, we conclude that Ann-II is transcriptionally up-regulated by NGF and that Ann-II-mediated plasmin generation may play an important role during neurite development in the differentiating PC-12 cell.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aminocaproic Acid / pharmacology
  • Animals
  • Annexin A2 / genetics
  • Annexin A2 / metabolism*
  • Antibodies
  • Cell Differentiation*
  • Cell Membrane / metabolism
  • Cells, Cultured
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / metabolism
  • Fibrinolysin / metabolism*
  • Gene Expression Regulation
  • Humans
  • Immunohistochemistry
  • Nerve Growth Factor / pharmacology*
  • Neurites / drug effects
  • Neurites / physiology*
  • Neurons / cytology*
  • PC12 Cells
  • Peptides / immunology
  • Peptides / metabolism
  • Proto-Oncogene Proteins p21(ras) / genetics
  • Proto-Oncogene Proteins p21(ras) / metabolism
  • Rats
  • Tissue Plasminogen Activator / immunology
  • Up-Regulation / physiology
  • Urokinase-Type Plasminogen Activator / immunology

Substances

  • Annexin A2
  • Antibodies
  • Peptides
  • Nerve Growth Factor
  • Tissue Plasminogen Activator
  • Fibrinolysin
  • Urokinase-Type Plasminogen Activator
  • HRAS protein, human
  • Proto-Oncogene Proteins p21(ras)
  • Aminocaproic Acid